| Filed On | Filing |
|---|---|
| 29 Jul 2026 |
Form 3: Severino Michael, Director
No securities owned |
| 04 Aug 2025 |
Form 3: Wong Ryan Ho-Yan, Chief Financial Officer
Holds 17,655 shares of Common Stock |
| 29 Nov 2024 |
Form 3: Rothfuss Cristin, EVP, General Counsel
Holds 11,817 shares of Common Stock |
| 16 Sep 2024 |
Form 3: Connelly Deirdre P, Director
No securities owned |
| 06 May 2024 |
Form 3: Murray Dallan, Chief Customer Officer
Holds 21,760 shares of Common Stock |
| 04 Jan 2023 |
Form 3: Arif Bilal, Chief Tech Ops Officer
Holds 22,917 shares of Common Stock |
| 06 Jun 2022 |
Form 3: Chambers Michael Andrew, Director
Holds 75,194 shares of Common Stock |
| 06 Jun 2022 |
Form 3: Boor Kathryn Jean, Director
No securities owned |
| 17 Nov 2021 |
Form 3: Mayo Stephen, Director
No securities owned |
| 05 Mar 2021 |
Form 3: Brown Ryan Edward, SVP, General Counsel
Holds 4,838 shares of Common Stock |
| 14 Dec 2020 |
Form 3: Rodino-Klapac Louise, Chief Scientific Officer
Holds 7,169 shares of Common Stock |
| 14 Dec 2020 |
Form 3: Estepan Ian Michael, Chief Financial Officer
Holds 14,042 shares of Common Stock |
| 05 Aug 2020 |
Form 3: Bratica Joseph, Principal Financial Officer
Holds 7,832 shares of Common Stock |
| 21 Jan 2020 |
Form 3: Martin John C, Director
No securities owned |
| 20 Nov 2019 |
Form 3: Ciambrone William, EVP
No securities owned |
| 11 Dec 2018 |
Form 3: Gray Mary Ann, Director
Holds 68 shares of Common Stock |
| 11 Jun 2018 |
Form 3: O'Neill Gilmore Neil, SVP & Chief Medical Officer
No securities owned |
| 05 Dec 2017 |
Form 3: Bonney Michael W, Director
Holds 0 shares of No Securities Owned |
| 25 Sep 2017 |
Form 3: Basi Guriqbal S., SVP, Chief Scientific Officer
No securities owned |
| 28 Jun 2017 |
Form 3: Ingram Douglas S, Director
No securities owned |
Loading...
